Dr. Bree Ann Zehm is a pharmacist who is specialized in Psychiatric in Spokane, Washington. Patients can reach her at 101 W 8th Ave, Spokane or contact her on 509-474-2188. Active license number of Dr. Bree Ann Zehm is PH00022039 for Psychiatric in Washington. Dr. Bree Ann Zehm is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Dr. Bree Ann Zehm speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Bree Ann Zehm
Specialization:
Psychiatric
Credentials:
PHARMD
Gender:
Female
Location:
101 W 8th Ave, Spokane, Washington, 99204-2307
Phone:
509-474-2188
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Bree Ann Zehm are as mentioned below.
NPI Number:
1942418306
NPI Enumeration Date:
18 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Bree Ann Zehm are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
PH00022039
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
101 W 8th Ave, Spokane, Washington
Zip:
99204-2307
Phone Number:
509-474-2188
Fax Number:
--
Patients can reach Dr. Bree Ann Zehm at 101 W 8th Ave, Spokane, Washington or can call on phone at 509-474-2188.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.